Dr Agarwal’s Healthcare IPO opens for subscription as GMP remains muted. Should you subscribe?

Dr Agarwal’s Healthcare IPO is now open for subscription, with a price range of Rs 382-402 per share. Despite a significant OFS component and rich pricing, analysts recommend investing for the long term. The company commands a 25% market share in India’s eye care service market, benefiting from industry growth projections.

More To Explore

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003